DK1309672T3 - Fremgangsmåde til fremstilling af infektiös reovirus - Google Patents

Fremgangsmåde til fremstilling af infektiös reovirus

Info

Publication number: DK1309672T3
Authority: DK; Denmark
Prior art keywords: producing infectious; infectious reovirus; reovirus; producing; infectious
Prior art date: 2000-08-10

Application number

DK01953084T

Other languages

Danish (da)

English (en)

Inventor

Matthew C Coffey

Bradley G Thompson

Original Assignee

Oncolytics Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-10

Filing date

2001-07-20

Publication date

2005-10-10

2001-07-20 Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc

2005-10-10 Application granted granted Critical

2005-10-10 Publication of DK1309672T3 publication Critical patent/DK1309672T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12051—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Mycology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK01953084T 2000-08-10 2001-07-20 Fremgangsmåde til fremstilling af infektiös reovirus DK1309672T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US22402600P	2000-08-10	2000-08-10
PCT/CA2001/001054 WO2002012435A1 (en)	2000-08-10	2001-07-20	Method of producing infectious reovirus

Publications (1)

Publication Number	Publication Date
DK1309672T3 true DK1309672T3 (da)	2005-10-10

Family

ID=22838987

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK05009952T DK1586634T3 (da)	2000-08-10	2001-07-20	Fremgangsmåde til fremstilling af infektiös reovirus
DK01953084T DK1309672T3 (da)	2000-08-10	2001-07-20	Fremgangsmåde til fremstilling af infektiös reovirus

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK05009952T DK1586634T3 (da)	2000-08-10	2001-07-20	Fremgangsmåde til fremstilling af infektiös reovirus

Country Status (19)

Country	Link
US (4)	US6528305B2 (pt)
EP (2)	EP1586634B1 (pt)
JP (2)	JP4009532B2 (pt)
AR (1)	AR033993A1 (pt)
AT (2)	ATE394475T1 (pt)
AU (2)	AU7562801A (pt)
BR (1)	BR0113122A (pt)
CA (1)	CA2415749C (pt)
DE (2)	DE60111747T2 (pt)
DK (2)	DK1586634T3 (pt)
ES (2)	ES2305940T3 (pt)
HK (1)	HK1082765A1 (pt)
IL (2)	IL153847A0 (pt)
MX (1)	MXPA03000846A (pt)
NZ (1)	NZ523510A (pt)
PT (2)	PT1309672E (pt)
TW (1)	TWI289158B (pt)
WO (1)	WO2002012435A1 (pt)
ZA (1)	ZA200300410B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6545492B1 (en) *	1999-09-20	2003-04-08	Europaisches Laboratorium Fur Molekularbiologie (Embl)	Multiple local probe measuring device and method
TWI289158B (en) *	2000-08-10	2007-11-01	Oncolytics Biotech Inc	Method of producing infectious reovirus
CA2437962C (en) *	2001-03-16	2005-11-15	Oncolytics Biotech Inc.	Method of extracting virus from cell culture
US20040115170A1 (en) *	2001-11-30	2004-06-17	Brown Earl Garnet	Oncolytic virus
CA2374388C (en) *	2002-02-28	2005-07-12	Matthew C. Coffey	The use of ribozymes in the detection of adventitious agents
US20040005546A1 (en)	2002-02-28	2004-01-08	Oncolytics Biotech Inc.	Use of ribozymes in the detection of adventitious agents
WO2003093460A1 (en) *	2002-04-29	2003-11-13	The Trustees Of The University Of Pennsylvania	Method for direct rescue and amplification of integrated viruses from cellular dna of tissues
WO2003093463A1 (en) *	2002-04-30	2003-11-13	Oncolytics Biotech Inc.	Improved viral purification methods
MXPA04011007A (es) *	2002-05-09	2005-02-14	Oncolytics Biotech Inc	Metodo para reducir el dolor usando virus oncoliticos.
EP1944035A1 (en)	2002-05-09	2008-07-16	Oncolytics Biotech Inc.	Method for reducing pain using oncolytic viruses
JP4546823B2 (ja) *	2002-05-10	2010-09-22	オンコリティクスバイオテク，インコーポレーテッド	腫瘍崩壊性ウイルスによる放射線療法に対する新生物細胞の感作
US7901921B2 (en)	2004-10-22	2011-03-08	Oncolytics Biotech Inc.	Viral purification methods
US7490608B2 (en) *	2005-06-17	2009-02-17	Nellcorr Puritan Bennett Llc	System and method for adjusting a gas delivery mask
US10668119B2 (en)	2005-08-01	2020-06-02	Virocure, Inc.	Attenuated reovirus
US10260049B2 (en)	2005-08-01	2019-04-16	Virocure, Inc.	Attenuated reovirus
JP2009525989A (ja) *	2006-02-13	2009-07-16	オンコリティクスバイオテク，インコーポレーテッド	腫瘍溶解性ウイルスの治療を増強させる局所的免疫抑制の使用
US8293498B2 (en)	2006-12-20	2012-10-23	Vanderbilt University	System for generation of viable reovirus from cloned cDNA
WO2008127486A2 (en) *	2006-12-29	2008-10-23	Bacilligen, Inc.	Replication-proficient dsrna capsids and uses thereof
EP2132315B1 (en)	2007-03-12	2015-07-15	Oncolytics Biotech Inc.	Reoviruses having modified sequences
US10369171B2 (en)	2007-03-13	2019-08-06	Virocure, Inc.	Attenuated reoviruses for selection of cell populations
TW200909581A (en) *	2007-05-21	2009-03-01	Oncolytics Biotech Inc	Mutant reoviruses and methods of making and using
AU2008316276A1 (en) *	2007-10-22	2009-04-30	Oncolytics Biotech Inc.	Treatment regime for proliferative disorders
US20110086005A1 (en) *	2008-05-27	2011-04-14	Oncolytics Biotech Inc.	Modulating interstitial pressure and oncolytic viral delivery and distribution
EP2296679A4 (en) *	2008-05-27	2012-03-21	Oncolytics Biotech Inc	SUPPRESSION OF PRODUCTION OF PRO-INFLAMMATORY CYTOKINES DURING ONCOLYTIC REOVIRUS THERAPY
WO2011126976A1 (en)	2010-04-07	2011-10-13	Vanderbilt University	Reovirus vaccines and methods of use therefor
CN102985536B (zh)	2010-04-14	2017-12-05	Emd密理博公司	生产高效价、高纯度的病毒母液的方法及使用其的方法
TW201233803A (en)	2010-12-02	2012-08-16	Oncolytics Biotech Inc	Lyophilized viral formulations
JP6034798B2 (ja)	2010-12-02	2016-11-30	オンコリティクスバイオテク，インコーポレーテッド	液体ウイルス製剤
ES2796950T3 (es)	2013-11-15	2020-11-30	Oncolytics Biotech Inc	Virus oncolíticos y regímenes reforzados para tratamiento de cáncer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4070453A (en) *	1976-06-25	1978-01-24	Syntex (U.S.A.) Inc.	Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines
US4559229A (en) *	1982-07-20	1985-12-17	Research Foundation	Avian proventriculitis vaccine
US5023252A (en)	1985-12-04	1991-06-11	Conrex Pharmaceutical Corporation	Transdermal and trans-membrane delivery of drugs
JPS6344532A (ja)	1986-08-11	1988-02-25	Biseibutsu Kagaku Kenkyusho:Kk	豚のレオウイルス感染症ワクチン
US5658779A (en)	1992-03-20	1997-08-19	Ligochem, Inc.	Method of adsorbing viruses from fluid compositions
JPH08214876A (ja)	1995-02-15	1996-08-27	Chemo Sero Therapeut Res Inst	ウイルスの調製法
WO1998022588A2 (en)	1996-11-20	1998-05-28	Introgen Therapeutics, Inc.	An improved method for the production and purification of adenoviral vectors
EP0993443A1 (de)	1997-06-24	2000-04-19	Basf Aktiengesellschaft	Verfahren zur herstellung von 4,4'-dihalogendiphenylsulfon
US6136307A (en) *	1997-08-13	2000-10-24	Oncolytics Biotech Inc.	Reovirus for the treatment of cellular proliferative disorders
US6110461A (en) *	1997-08-13	2000-08-29	Oncolytics Biotech Inc.	Reovirus for the treatment of neoplasia
AR028039A1 (es)	2000-05-03	2003-04-23	Oncolytics Biotech Inc	Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
TWI289158B (en) *	2000-08-10	2007-11-01	Oncolytics Biotech Inc	Method of producing infectious reovirus

2001
- 2001-07-19 TW TW90117712A patent/TWI289158B/zh not_active IP Right Cessation
- 2001-07-20 PT PT01953084T patent/PT1309672E/pt unknown
- 2001-07-20 ES ES05009952T patent/ES2305940T3/es not_active Expired - Lifetime
- 2001-07-20 AU AU7562801A patent/AU7562801A/xx active Pending
- 2001-07-20 EP EP20050009952 patent/EP1586634B1/en not_active Expired - Lifetime
- 2001-07-20 CA CA 2415749 patent/CA2415749C/en not_active Expired - Lifetime
- 2001-07-20 MX MXPA03000846A patent/MXPA03000846A/es active IP Right Grant
- 2001-07-20 DK DK05009952T patent/DK1586634T3/da active
- 2001-07-20 WO PCT/CA2001/001054 patent/WO2002012435A1/en active IP Right Grant
- 2001-07-20 AT AT05009952T patent/ATE394475T1/de not_active IP Right Cessation
- 2001-07-20 NZ NZ523510A patent/NZ523510A/en unknown
- 2001-07-20 AT AT01953084T patent/ATE298788T1/de not_active IP Right Cessation
- 2001-07-20 BR BR0113122A patent/BR0113122A/pt not_active IP Right Cessation
- 2001-07-20 DK DK01953084T patent/DK1309672T3/da active
- 2001-07-20 DE DE2001611747 patent/DE60111747T2/de not_active Expired - Lifetime
- 2001-07-20 ZA ZA200300410A patent/ZA200300410B/xx unknown
- 2001-07-20 IL IL15384701A patent/IL153847A0/xx active IP Right Grant
- 2001-07-20 DE DE60133947T patent/DE60133947D1/de not_active Expired - Lifetime
- 2001-07-20 JP JP2002517726A patent/JP4009532B2/ja not_active Expired - Lifetime
- 2001-07-20 EP EP01953084A patent/EP1309672B1/en not_active Expired - Lifetime
- 2001-07-20 ES ES01953084T patent/ES2241844T3/es not_active Expired - Lifetime
- 2001-07-20 PT PT05009952T patent/PT1586634E/pt unknown
- 2001-07-20 AU AU2001275628A patent/AU2001275628B2/en not_active Expired
- 2001-08-02 US US09/920,012 patent/US6528305B2/en not_active Expired - Lifetime
- 2001-08-03 AR ARP010103738 patent/AR033993A1/es active IP Right Grant
2003
- 2003-01-08 US US10/337,911 patent/US6703232B2/en not_active Expired - Lifetime
- 2003-01-08 IL IL153847A patent/IL153847A/en unknown
- 2003-12-11 US US10/734,552 patent/US7049127B2/en not_active Expired - Lifetime
2006
- 2006-03-27 US US11/390,885 patent/US7429485B2/en not_active Expired - Lifetime
- 2006-04-03 HK HK06104055A patent/HK1082765A1/xx not_active IP Right Cessation
- 2006-08-30 JP JP2006234596A patent/JP2006314336A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
DE60133947D1 (de)	2008-06-19
EP1309672A1 (en)	2003-05-14
TWI289158B (en)	2007-11-01
ATE298788T1 (de)	2005-07-15
US7429485B2 (en)	2008-09-30
US20030166253A1 (en)	2003-09-04
AU2001275628B2 (en)	2007-08-30
PT1586634E (pt)	2008-06-19
AU7562801A (en)	2002-02-18
BR0113122A (pt)	2003-07-22
US20040126869A1 (en)	2004-07-01
DE60111747D1 (de)	2005-08-04
EP1586634A1 (en)	2005-10-19
PT1309672E (pt)	2005-09-30
JP2004505623A (ja)	2004-02-26
ES2305940T3 (es)	2008-11-01
US20060165724A1 (en)	2006-07-27
AR033993A1 (es)	2004-01-21
US6703232B2 (en)	2004-03-09
US6528305B2 (en)	2003-03-04
EP1309672B1 (en)	2005-06-29
CA2415749A1 (en)	2002-02-14
US20020037576A1 (en)	2002-03-28
HK1082765A1 (en)	2006-06-16
US7049127B2 (en)	2006-05-23
WO2002012435A1 (en)	2002-02-14
DK1586634T3 (da)	2008-08-18
NZ523510A (en)	2004-08-27
JP4009532B2 (ja)	2007-11-14
IL153847A (en)	2007-10-31
DE60111747T2 (de)	2006-04-27
AU2001275628B8 (en)	2002-02-18
EP1586634B1 (en)	2008-05-07
ES2241844T3 (es)	2005-11-01
JP2006314336A (ja)	2006-11-24
ZA200300410B (en)	2004-01-26
MXPA03000846A (es)	2004-04-05
ATE394475T1 (de)	2008-05-15
CA2415749C (en)	2009-05-12
IL153847A0 (en)	2003-07-31

Publication	Publication Date	Title
DK1309672T3 (da)	2005-10-10	Fremgangsmåde til fremstilling af infektiös reovirus
DK1187231T3 (da)	2007-04-10	Metode til fremstilling af oxid-superleder
DK1303478T3 (da)	2004-08-30	Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1978747T3 (da)	2014-06-10	Fremgangsmåde til fjernelse af kodningsforvrængning
DK1296935T3 (da)	2009-06-22	Fremgangsmåde til fremstilling af substituerede octanoylamider
DE60139615D1 (de)	2009-10-01	Verbundmembran und herstellungsverfahren
DK1169314T3 (da)	2002-10-14	Krystallinsk base af citalopram
DK1432319T3 (da)	2011-04-11	Fremgangsmåde til fremstilling af hundefoder
DK1309582T3 (da)	2005-03-14	Fremgangsmåde til fremstilling af citalopram
DK2135957T3 (da)	2019-05-13	Fremgangsmåde til fremstilling af glucaner
DK1353923T3 (da)	2005-01-31	Forbedret fremgangsmåde til syntese af carbapenem
DE60130046D1 (de)	2007-09-27	Knotenauswahlverfahren
DK1326836T3 (da)	2004-06-01	Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1294659T3 (da)	2008-03-17	Fremgangsmåde til isolering af katamin
DK1296970T3 (da)	2008-07-14	Fremgangsmåde til fremstilling af citalopram
IS6716A (is)	2003-02-13	Aðferðir við að framleiða sílostasól
DK1286940T3 (da)	2006-07-31	Fremgangsmåde til fluormethylering af alkoholer
NO20032563D0 (no)	2003-06-05	Filtreringsfremgangsmåte
DK1286941T3 (da)	2005-10-10	Syntetisk fremgangsmåde til fluormethylering af halogenerede alkoholer
DE10294532D2 (de)	2004-08-26	Künstlicher Lymphknoten
ES1048083Y (es)	2001-11-01	Bielas avanzadas de empuje tangencial
DK1229109T3 (da)	2004-02-02	Fremgangsmåde til fremstilling af glucose-1-phosphat
NO20023714L (no)	2002-10-03	Ny koblingsprosess
DK1296983T3 (da)	2005-02-21	Ny fremgangsmåde til fremstilling af pyrazolopyrimidinoner
SE0104471D0 (sv)	2001-12-28	New method